IQVIA creates intelligent connections to accelerate medication development by combining its clinical trial operations expertise, purpose-built technologies portfolio, and data management capabilities.
A new SaaS-based clinical data analytics platform from IQVIA Technologies harnesses structured and unstructured data into a single, standardized ecosystem for interrogation.
Clinical Data Analytics Suite (CDAS) uses advanced ML-enhanced analysis to identify more predictive and previously hidden insights, empowering stakeholders to make smarter decisions across the trial journey.
Clinical data analytics platforms can improve process transparency, eliminate data siloes, and most importantly provide a foundation for more advanced technologies aiding new trial approaches.
GARTNER, HYPE CYCLE FOR LIFE SCIENCE RESEARCH AND DEVELOPMENT, JEFF SMITH, MICHAEL SHANLER, 13 AUGUST 2020
IQVIA creates intelligent connections to accelerate medication development by combining its clinical trial operations expertise, purpose-built technologies portfolio, and data management capabilities.
A modern foundation built for scale and performance regardless of the complexity of a trial, and based on IQVIA’s multi-cloud, multi-tenant, API-driven Human Data Sciences Cloud.
Users have control over data management and analytics with faster results and fewer demands on IT, including an intuitive console to discover ingested data and flexible tools for visualizations and hypothesis testing.
A vendor-agnostic repository that integrates an increasing volume, variety, and velocity of data, facilitating analysis across clinical studies, systems, and stakeholders.
Intelligent Apps are a catalog of IQVIA developed, AI/ML-driven algorithms that can be consumed via the IQVIA API Marketplace. Intelligent Applications deliver efficient, accelerated time to operational automation by leveraging a reusable library of algorithms designed for pharma data and insertion directly into your workflows.
CDAS is a part of IQVIA Technologies’Orchestrated Clinical Trials (OCT)platform, which is comprised of primarily SaaS applications integrated from the ground-up. OCT eases the burden on your sites and makes it easier and more appealing for patients to remain engaged, produces faster trials to database lock, and speeds time to market.
For example, CDAS works seamlessly with IQVIADigital Trial Management Suite (DTMS)to provide data management and advanced analytics for Risk-based Monitoring, CRA Central, and CTMS.
Ease the burden on your sites and make it easier and more appealing for patients to enroll and remain engaged.
Orchestrate outcomes for efficient clinical trials with an innovative CTMS and dynamic monitoring.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Get in touch today to discover the right solutions for you.
We are pleased to speak with you during our standard business hours.
U.S. Toll-Free only
+1 866 267 4479
For international call please find a number in ourtoll-free list.